Azitra, Inc. is a preclinical company that aims to harness the power of the microbiome on the skin. Since 2014, the company has been working with world-leading scientists in dermatology, microbiology, and microbiomics to improve and test its platform.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/05/17 | $3,750,000 | Series A |
Bios Partners | undisclosed |
| 05/03/18 | $2,150,000 | Convertible Debt |
Bios Partners Connecticut Innovations KdT Ventures | undisclosed |
| 10/15/19 | $14,000,000 | Series A |
Bios Partners Connecticut Innovations Godfrey Capital KdT Ventures | undisclosed |
